Tyson Foods (TSN)
NYSEConsumer StaplesAgricultural Farm ProductsSnapshot 2026-09-04
$51.42-0.66%
Close 2026-09-04 · 1-day change
NYSEConsumer StaplesAgricultural Farm ProductsSnapshot 2026-09-04
QuarterlyIQ Insights · TSN
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $51 TSN trades at 13× p/e, in line with its 13× p/e peer median — but our blended $59 fair value sits above the price. We hold it with medium confidence: our number sits below the analyst range. Analysts target $63–$78. Note: our $59 fair value sits below the entire analyst range ($63–$78). Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $65.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $8.30 | — | — | Analyst | high |
| dcf fcff | 12M | $134.17 | — | — | Analyst | high |
| graham number | 12M | $67.73 | — | — | TTM | high |
| Peer EV/EBITDA | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$63.00 – $78.00 (median $65.50) · 6 analysts · as of 2026-09-04
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Roughly priced in line with peers.
Cheaper than its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $31.77 |
| 8.5 |
| 6.15 |
| TTM |
| high |
| Peer P/FCF | 12M | $38.11 | 11.7 | 3.27 | TTM | high |
| Peer P/E | 12M | $49.92 | 12.5 | 3.98 | TTM | high |
| Peer P/S | 12M | $116.05 | 0.7 | 156.88 | TTM | high |
| PEG | 12M | $155.93 | 39.2 | 3.98 | TTM | high |
| residual income | 12M | $50.80 | — | — | TTM | high |
| Own P/E history | 12M | $58.57 | 14.7 | 3.98 | TTM | high |
| triangulated | 12M | $54.08 | 12.5 | 4.31 | Triangulated | high |
| Peer P/E | 3Y | $59.85 | 12.5 | 4.77 | Analyst | medium |
| Peer P/S | 3Y | $120.42 | 0.7 | 162.80 | Analyst | medium |
| PEG | 3Y | $186.94 | 39.2 | 4.77 | Analyst | medium |
| Own P/E history | 3Y | $70.22 | 14.7 | 4.77 | Analyst | medium |
| Peer P/E | 5Y | $62.04 | 12.5 | 4.95 | Analyst | high |
| Peer P/S | 5Y | $124.82 | 0.7 | 168.74 | Analyst | high |
| PEG | 5Y | $193.77 | 39.2 | 4.95 | Analyst | high |
| Own P/E history | 5Y | $72.79 | 14.7 | 4.95 | Analyst | high |